Hepatic arterial infusion of oxaliplatin plus raltitrexed in patients with intermediate and advanced stage hepatocellular carcinoma: A phase II, single-arm, prospective study
Author:
Funder
Guiding Project of Science and Technology Program of Fujian Province, China
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference29 articles.
1. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016
2. Hepatocellular carcinoma;Forner;Lancet,2018
3. A comparative study between sorafenib and hepatic arterial Infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis;Song;J Gastroenterol,2015
4. Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis;Choi;Cancer Chemother Pharmacol,2018
5. Effcacy and safety of sorafenib in patients in the Asia-Pacifc region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial;Cheng;Lancet Oncol,2009
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) as a Near-term Prognostic Indicator in Patients with Locally Advanced Hepatocellular Carcinoma Treated with Hepatic Artery Infusion Chemotherapy: A Propensity Score Matching Cohort Study;2024-01-18
2. Tyrosine kinase inhibitors, immune checkpoint inhibitors combined with hepatic arterial infusion of oxaliplatin and raltitrexed versus oxaliplatin, 5-fluorouracil and leucovorin for intermediate and advanced hepatocellular carcinoma: A retrospective study;International Immunopharmacology;2023-12
3. Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations;Hepatology International;2023-10-21
4. The feasibility and safety of the brachial artery approach in the treatment of hepatic artery infusion chemotherapy: a retrospective study;Journal of Gastrointestinal Oncology;2023-08
5. Hepatic Arterial Infusion Chemotherapy with Oxaliplatin Plus Raltitrexed as an Alternative Option in Advanced Hepatocellular Carcinoma Patients with Failure of, or Unsuitability for, Transarterial Chemoembolization;Medicina;2022-09-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3